AbstractThe second osmotic virial coefficients (b2) of four proteins – lysozyme, recombinant human lactoferrin, concanavalin A and catalase were measured by self-interaction chromatography (SIC) in solutions of varying salt type, concentration and pH. Protein aggregate sizes based on the initial hydrodynamic radius of the protein solution species present were measured using dynamic light scattering, and the relationship between b2 and protein aggregate size was studied. A linear correlation was established between b2 values and protein aggregate hydrodynamic size for all proteins, and for almost all solution conditions. Aggregate sizes of <∼10nm, indicative of non-aggregated protein systems, were consistently observed to have b2 values >0. ...
AbstractWeak protein interactions are often characterized in terms of the osmotic second virial coef...
Roberts, Christopher J.The diverse behavior of protein solutions can be attributed to the collection...
AbstractFormulation development presents significant challenges with respect to protein therapeutics...
The second osmotic virial coefficients (b2) of four proteins – lysozyme, recombinant human lactoferr...
One key barrier to the timely and efficient production of biopharmaceuticals is that they are prone ...
Protein aggregation is a critical problem in the manufacture of biopharmaceutical, effecting process...
AbstractProtein self-interaction is important in protein crystal growth, solubilization, and aggrega...
The relationship of second virial coefficient, B22 with solubility is reviewed and its relationship ...
The relationship of second virial coefficient, B22 with solubility is reviewed and its relationship ...
The relationship of second virial coefficient, B22 with solubility is reviewed and its relationship ...
AbstractProtein self-interaction is important in protein crystal growth, solubilization, and aggrega...
AbstractWeak protein interactions are often characterized in terms of the osmotic second virial coef...
AbstractThe concentration-dependence of the diffusion and sedimentation coefficients (kD and ks, res...
The number of protein containing therapeutic drugs is growing day by day. Lack of proper storage con...
Biotherapeutics, especially monoclonal antibodies (mAbs), is one of the fastest growing groups of ph...
AbstractWeak protein interactions are often characterized in terms of the osmotic second virial coef...
Roberts, Christopher J.The diverse behavior of protein solutions can be attributed to the collection...
AbstractFormulation development presents significant challenges with respect to protein therapeutics...
The second osmotic virial coefficients (b2) of four proteins – lysozyme, recombinant human lactoferr...
One key barrier to the timely and efficient production of biopharmaceuticals is that they are prone ...
Protein aggregation is a critical problem in the manufacture of biopharmaceutical, effecting process...
AbstractProtein self-interaction is important in protein crystal growth, solubilization, and aggrega...
The relationship of second virial coefficient, B22 with solubility is reviewed and its relationship ...
The relationship of second virial coefficient, B22 with solubility is reviewed and its relationship ...
The relationship of second virial coefficient, B22 with solubility is reviewed and its relationship ...
AbstractProtein self-interaction is important in protein crystal growth, solubilization, and aggrega...
AbstractWeak protein interactions are often characterized in terms of the osmotic second virial coef...
AbstractThe concentration-dependence of the diffusion and sedimentation coefficients (kD and ks, res...
The number of protein containing therapeutic drugs is growing day by day. Lack of proper storage con...
Biotherapeutics, especially monoclonal antibodies (mAbs), is one of the fastest growing groups of ph...
AbstractWeak protein interactions are often characterized in terms of the osmotic second virial coef...
Roberts, Christopher J.The diverse behavior of protein solutions can be attributed to the collection...
AbstractFormulation development presents significant challenges with respect to protein therapeutics...